Cargando…

PCSK9 inhibition in high-risk patients

Detalles Bibliográficos
Autores principales: Zijlstra, Laurien E., Mooijaart, Simon P., Jukema, J. Wouter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932888/
https://www.ncbi.nlm.nih.gov/pubmed/31829977
http://dx.doi.org/10.18632/aging.102621
_version_ 1783483098971766784
author Zijlstra, Laurien E.
Mooijaart, Simon P.
Jukema, J. Wouter
author_facet Zijlstra, Laurien E.
Mooijaart, Simon P.
Jukema, J. Wouter
author_sort Zijlstra, Laurien E.
collection PubMed
description
format Online
Article
Text
id pubmed-6932888
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-69328882020-01-03 PCSK9 inhibition in high-risk patients Zijlstra, Laurien E. Mooijaart, Simon P. Jukema, J. Wouter Aging (Albany NY) Editorial Impact Journals 2019-12-11 /pmc/articles/PMC6932888/ /pubmed/31829977 http://dx.doi.org/10.18632/aging.102621 Text en Copyright © 2019 Zijlstra et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Zijlstra, Laurien E.
Mooijaart, Simon P.
Jukema, J. Wouter
PCSK9 inhibition in high-risk patients
title PCSK9 inhibition in high-risk patients
title_full PCSK9 inhibition in high-risk patients
title_fullStr PCSK9 inhibition in high-risk patients
title_full_unstemmed PCSK9 inhibition in high-risk patients
title_short PCSK9 inhibition in high-risk patients
title_sort pcsk9 inhibition in high-risk patients
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932888/
https://www.ncbi.nlm.nih.gov/pubmed/31829977
http://dx.doi.org/10.18632/aging.102621
work_keys_str_mv AT zijlstralauriene pcsk9inhibitioninhighriskpatients
AT mooijaartsimonp pcsk9inhibitioninhighriskpatients
AT jukemajwouter pcsk9inhibitioninhighriskpatients